Anti-hyperglycemic effects of Eryngium billardierei F. Delaroche extract on insulin-resistance HepG2 cells in vitro

Background Insulin resistance as a major problem is associated with type 2 diabetes mellitus. This study investigated the effect of Eryngium billardierei on insulin-resistance induced HepG2 cells. Methods and results MTT method was used to evaluate the viability of HepG2 cells treated with various doses of E. billardierei extract. An insulin-resistance model was established in HepG2 cells. Next, MTT assay and Acridine orange staining were performed to investigate the viability of cells in the vicinity of different concentrations of insulin, pioglitazone, and E. billardierei extract in an insulin-resistance media. The glucose uptake test was performed to select the optimal insulin concentration. Expression levels of IR, G6Pase, and PEPCK genes were assessed by real-time RT-PCR. According to obtained data, E. billardierei at concentrations of 0.5 and 1 mg/mL show no toxicity on cells. Furthermore, based on MTT assay and glucose uptake test 10(-5) mol/L insulin was chosen as the model group to induce insulin-resistance in HepG2 cells for gene expression analysis. Finally, 1 mg/mL E. billardierei not only induced no cytotoxicity but also showed an increase in the expression of IR as well as a reduction in G6Pase and PEPCK level compared to the control and model groups. Conclusions The obtained data indicated that 1 mg/mL E. billardierei might have an anti-insulin resistance effect on insulinresistance HepG2 cells in vitro and could be a promising candidate with anti-hyperglycemic properties for diabetes treatments. [GRAPHICS] .

Automated summary

This study investigated the effect of Eryngium billardierei on insulin-resistance induced HepG2 cells. The results showed that 1 mg/mL E. billardierei had no toxicity on cells and increased the expression of IR, while reducing the levels of G6Pase and PEPCK.